We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microfluidic Device Could Improve Biomarker Analyses

By LabMedica International staff writers
Posted on 08 Jul 2014
A new microfluidic device could offer a more reliable alternative for detecting biomarkers in patients facing such illnesses as cancer or malaria. More...


The physical attributes of cells are important biomarkers in medicine, whether extracting circulating tumor cells from the blood of a cancer patient, or to measure the elasticity of red blood cells due to malaria infection.

Scientists at The Royal Institute of Technology (KTH; Stockholm, Sweden) proposed a microfluidic device that can sort elastic capsules by their deformability. The device consists of a duct embedded with a semi-cylindrical obstacle, and a diffuser which further enhances the sorting capability. The KTH team used extensive computational simulations to model a microfluidic device that would sort cells according to their elasticity. The work draws on numerical techniques and computational capabilities developed in the last decade to handle the complexity of microscale flows.

Most cell sorting techniques rely on the difference between chemical properties of the cells. The problem is chemical properties do not give pathologists the full picture. Two cells can have very similar chemical properties, but different physical properties. Size, shape and elasticity, or deformability, are important attributes that can be also enable cell sorting, given the right kind of device.

The scientists demonstrated that the device can operate reasonably well under changes in the initial position of the capsule. The efficiency of the device remains essentially unaltered under small changes of the obstacle shape from semicircular to semi-elliptic cross-section. Confinement along the direction perpendicular to the plane of the device increases its efficiency. This work is the first numerical study of cell sorting by a realistic microfluidic device.

Dhrubaditya Mitra, PhD, an assistant professor in theoretical physics and a coauthor of the study offers an example of why elasticity matters. “If you are infected with malaria, the physical nature of your red blood cells changes. They become harder and red blood cells also become harder as they get older too. These harder red blood cells are filtered by the spleen which acts like a sieve. The softer red blood cells can squeeze through the gaps but the harder ones cannot.” The study was published on June 20, 2014, in the journal Soft Matter.

Related Links:

The Royal Institute of Technology



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.